A lack of access: Pharma is failing to ensure new antibiotics will be available to poor countries, analysis finds
Ed Silverman covers the findings of the latest Antimicrobial Resistance Benchmark in his column and newsletter, Pharmalot.
Date
22 November 2021
"Although the pharmaceutical industry is making modest progress in countering resistance to superbugs, drug companies are not doing enough to ensure greater access to lifesaving antibiotics in low and middle-income countries, a new analysis finds,"Â writes journalist Ed Silverman in a report for Stat News.
The article covers the findings of the 2021 Antimicrobial Resistance Benchmark.
Click to read more on the Stat website (paywall).